Search for a rare disease
Other search option(s)
Congenital factor II deficiency
An inherited bleeding disorder due to reduced activity of factor II (FII, prothrombin) and characterized by mucocutaneous bleeding symptoms.
ORPHA:325Classification level: Disorder
- Prothrombin deficiency
- Prevalence: <1 / 1 000 000
- Inheritance: Autosomal recessive
- Age of onset: All ages
- ICD-10: D68.2
- OMIM: 613679
- UMLS: C0020640 C0272317 C3203356
- MeSH: -
- GARD: -
- MedDRA: -
Factor II deficiency is the most rare coagulation factor deficiency. Prevalence of homozygous forms is estimated at 1/2,000,000. Both sexes are equally affected.
Congenital FII deficiency can manifest at any age, with severe forms of the disease manifesting early in life. Common clinical signs include epistaxis, menorrhagia, oral cavity bleedings, mucosal bleeding, soft tissue bleeding, hemarthroses, easy bruising, and prolonged bleeding after tooth extraction, trauma or surgery. Severe forms may present intracranial hemorrhage or umbilical bleeding. The severity of the bleeding manifestations correlates with the FII levels.
Inherited FII deficiency is caused by mutations in the F2 gene (11p11-q12) encoding prothrombin.
Diagnosis is based on prolonged prothrombin and activated partial thromboplastin times (PT, aPTT) and on low FII coagulant activity measured using a PT based assay. Molecular testing is available, but is unnecessary for diagnosis.
Differential diagnoses include deficiencies of factors V, VII, X, VIII, IX, XI, XIII or acquired deficiencies in FII (lupus anticoagulant) (see these terms).
Transmission is autosomal recessive.
Management and treatment
Prothrombin Complex Concentrates (PCCs) or fresh frozen plasma (if PCCs are not available) is usually used to treat hemorrhagic episodes.
Prognosis is good with early diagnosis and adequate treatment.
Article for general public
- Clinical genetics review
- English (2014)